Skip to content

Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)

A Randomized Control Trial Comparing Two Methods of Delivering Continuous Positive Airway Pressure (CPAP), Infant Flow System CPAP and Bubble CPAP, in Supporting Successful Extubation of Infants of Birth Weights Less Than or Equal to 1500 Grams at Birth (C2CPAP)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00187434
Enrollment
76
Registered
2005-09-16
Start date
2003-09-30
Completion date
Unknown
Last updated
2007-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth, Respiratory Insufficiency

Keywords

premature infant, supporting extubation

Brief summary

Continuous positive airway pressure (CPAP) has been used successfully to promote extubation in the premature infant population. The two methods of CPAP to be examined are currently used by many institutions, yet no study has compared these methods to determine which is better in the population of newborns \< 1500 grams (birth weight) at supporting extubation. This randomised controlled study will examine two types of CPAP: the Infant Flow System and the Bubble CPAP. This randomised controlled, single site, clinical study is to determine whether the Bubble CPAP or the Infant Flow System (IFS) CPAP is more effective at supporting the extubation in infants of birth weights \< 1500 grams. Seventy-six infants will be randomised, immediately prior to extubation, to IFS or Bubble CPAP of 5 cmH2O. The primary outcome is successful extubation, defined as not reaching failure criteria for the 7 days post-extubation. Failure criteria are defined as pH \< 7.25 and PCO2 \> 65 mmHg or a sustained increase in FiO2 of 0.15.

Detailed description

Background: Continuous Positive Airway Pressure (CPAP) has been used successfully to promote extubation in the premature infant population (Davis & Henderson-Smart, 2002). The two methods of CPAP to be examined are used by many institutions, yet no study has compared these methods to determine which is better in the population of newborns \< 1500 grams (birth weight) at supporting extubation. This study may have cost savings implications. If bubble CPAP is shown to be as effective in this application neonatal intensive care units (NICUs) will have a more affordable option of providing effective CPAP. Methods: This randomised controlled, single site, clinical study is to determine if Bubble CPAP or Infant Flow System (IFS) CPAP is more effective at supporting extubation in infants of birth weights \< 1500 grams. Seventy-six infants will be randomised immediately prior to extubation to IFS or Bubble CPAP of 5 cmH2O. The primary outcome is successful extubation, defined as not reaching failure criteria for the 7 days post-extubation. Failure criteria are defined as pH \< 7.25 and PCO2 \> 65 mmHg or a sustained increase in FiO2 of 0.15. Participants: Parents/guardians of eligible infants will be approached and given information regarding the study, and any questions answered. They will then be allowed to consider study participation in private. The recruiter will return at an agreed time and informed consent will be obtained from those agreeing to participate. Parents will be approached in accordance with the guidelines of the NICU @ SWCHSC. Infants are eligible if birth weight \< 1500 grams, are to be extubated to CPAP and have no known airway anomalies, or suspected genetic anomalies. Analysis: Multiple ANOVA analysis will be used for continuous variables, chi-square for categorical variables, including primary outcome. Conclusion: The results of this study will determine which method of CPAP is the best method of supporting extubation in the \< 1500 g infant.

Interventions

DEVICEInfant Flow System

Sponsors

Ontario Lung Association
CollaboratorOTHER
Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Intubated infant * ≤ 1500 grams at birth * Decision to extubate to CPAP made by the clinical team * Written informed consent obtained

Exclusion criteria

* Have known airway anomalies * Have grade III or IV or periventricular leukomalacia * Have known or suspected genetic syndromes

Design outcomes

Primary

MeasureTime frame
failure of extubation as defined by the following: pH < 7.25 and PCO2 > 65 (or an increase of 15 mmHg from pre-extubation), a sustained (> 1 hour) increase in FiO2 of .15 (as compared to pre-extubation) or significant apno

Secondary

MeasureTime frame
reintubation
length of time in days on CPAP
corrected gestational age at cessation of CPAP
average weight gain on CPAP
assessment of pain will

Countries

Canada

Contacts

Primary ContactMarilyn D Hyndman
marilyn.hyndman@sw.ca416 323 6400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026